See also:

1. Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis Multiple Sclerosis Journal, Volume 23, Issue 10, Page 1424-1427, September 2017. Read More......
2. A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS Multiple Sclerosis Journal, Volume 23, Issue 10, Page 1309-1319, September 2017. Read More......
3. Impairment of social cognition in multiple sclerosis: Amygdala atrophy is the main predictor Multiple Sclerosis Journal, Volume 23, Issue 10, Page 1358-1366, September 2017. Read More......
4. Corrigendum: Enhanced creative thinking under dopaminergic therapy in Parkinson disease Read More......